Combatting disease with antibody drug conjugates
Tune into this episode where we investigate how antibody drug conjugates can be optimised, as well as the future of the field.
List view / Grid view
Tune into this episode where we investigate how antibody drug conjugates can be optimised, as well as the future of the field.
In this episode, we explore how mRNA technology could revolutionise cancer therapeutics.
In this episode, we discuss the current advantages and limitations of using organoids, as well as where the field is heading.
A study has shown that SRI-37330 is successful at improving the characteristics of diabetes in human pancreatic islets and animal models.